Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Psoriatic arthritis
•
General Rheumatology
•
Dermatology
Would you continue TNF-inhibitor in a patient with psoriatic arthritis who has had multiple nonmelanoma skin cancers requiring Mohs surgery?
Related Questions
How do you approach managing nausea and GI side effects when initiating methotrexate?
Are you comfortable with using NSAIDs in a patient on methotrexate for inflammatory arthritis?
Would you switch azathioprine to a different immunosuppressant if a controlled patient with SLE develops melanoma and/or non-melanoma skin cancer?
Does your institution have formal policies or work flows to reduce unnecessary IGRAs ordered for patients on biologics?
How do you approach use of DMARDs and/or biologics for inflammatory arthritis in patients with a history of seizure disorder on anti-epileptic medications?
How do you approach treatment of SAPHO syndrome?
What is your approach to evaluation in patients who present with erythromelalgia?
Does the presence of calcified granulomas on chest imaging influence your choice of biologic for treatment of psoriatic arthritis (or rheumatoid arthritis)?
What is your approach to treatment in patients with cutaneous mastocytosis and inflammatory arthritis?
How do you counsel and manage joint pain after isotretinoin treatment?
